We demonstrated that, in contrast to classical opioid receptors, ACKR3 would not trigger classical G protein signaling and is not modulated by the classical prescription or analgesic opioids, which include morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we founded that LIH383, an ACKR3-selective https://llahh035ifa4.theblogfairy.com/profile